13F-HR filed by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-07-22, with 88 holding rows worth $907,850,000.
- Accession
- 0001213900-19-013307
- Filer
- CIK 1599882
- Filed
- 2019-07-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 88 entries on the cover page, a total value of $907,850,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $907,850,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 185,232 | $33,968,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 105,000 | $27,857,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 187,171 | $26,683,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 203,017 | $26,591,000 | thousands by filing date | |
| HORIZON BANCORP IND | 440407104 | COM | 1,087,656 | $26,169,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 725,000 | $25,796,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 105,000 | $25,621,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 90,000 | $25,399,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 92,900 | $24,200,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 281,349 | $24,098,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 365,899 | $23,136,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 259,552 | $21,828,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 80,000 | $20,161,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 412,093 | $19,171,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 182,008 | $18,747,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 343,768 | $18,732,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 750,700 | $18,407,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 136,164 | $18,405,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 235,911 | $17,788,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 160,000 | $17,726,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 387,908 | $16,672,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 162,883 | $15,863,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 347,439 | $15,697,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 295,000 | $15,470,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 338,386 | $15,346,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 180,000 | $15,197,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 96,191 | $15,155,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 857,169 | $14,546,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 45,014 | $14,089,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 319,792 | $13,089,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 949,833 | $12,329,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 141,520 | $12,066,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 851,367 | $11,808,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 225,024 | $11,283,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 150,000 | $10,794,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 90,000 | $10,624,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 200,000 | $9,976,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 170,000 | $9,967,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 460,000 | $9,830,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 135,374 | $9,369,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 70,000 | $8,904,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 29,800 | $8,752,000 | thousands by filing date | |
| OMNICELL COM COM | 68213N109 | Stock | 100,375 | $8,635,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 390,000 | $8,619,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 793,957 | $8,551,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 100,000 | $8,496,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 274,274 | $8,409,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 260,000 | $7,683,000 | thousands by filing date | |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 493,999 | $7,568,000 | thousands by filing date | |
| DIPLOMAT PHARMACY INC | 25456K101 | COM | 1,203,405 | $7,329,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 200,000 | $7,294,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 229,000 | $6,886,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 350,800 | $6,802,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 493,679 | $6,196,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 81,550 | $5,917,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 2,264,942 | $5,911,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 664,023 | $5,850,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 31,585 | $5,835,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 1,234,335 | $4,925,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 500,329 | $4,783,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 21,639 | $3,962,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 37,225 | $3,902,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 120,000 | $3,642,000 | thousands by filing date | |
| HMS HLDGS CORP | 40425J101 | COM | 100,000 | $3,239,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 149,201 | $3,106,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 649,123 | $3,103,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 37,600 | $2,992,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 70,000 | $2,876,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 120,399 | $2,714,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 193,181 | $2,506,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 60,000 | $2,438,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 291,499 | $2,419,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 119,673 | $1,423,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 300,000 | $1,410,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 10,000 | $1,024,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 277,800 | $745,000 | thousands by filing date | |
| Chevron Corporation | 166764100 | COM | 2,974 | $370,000 | thousands by filing date | |
| International Business Machines Corporation | 459200101 | COM | 2,215 | $305,000 | thousands by filing date | |
| ANHEUSER BUSCH INBEV SA NV SPONSORED ADR | 03524A108 | ADR | 3,409 | $302,000 | thousands by filing date | |
| FORD MTR CO COM | 345370860 | Stock | 29,164 | $298,000 | thousands by filing date | |
| EXXON MOBIL CORP | 30231G102 | COM | 3,854 | $295,000 | thousands by filing date | |
| Walt Disney Co | 254687106 | COM | 2,083 | $291,000 | thousands by filing date | |
| JPMorgan Chase & Co | 46625H100 | COM | 2,472 | $276,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 377,244 | $274,000 | thousands by filing date | |
| Qualcomm Incorporated | 747525103 | COM | 3,391 | $258,000 | thousands by filing date | |
| Wells Fargo & Company | 949746101 | COM | 5,272 | $249,000 | thousands by filing date | |
| JANUS HENDERSON GROUP PLC ORD SHS | G4474Y214 | Stock | 10,645 | $228,000 | thousands by filing date | |
| Microsoft Corp | 594918104 | COM | 1,532 | $205,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-19-013307 | this filing | 2019-07-22 | acceptance time not in the bulk data set |